News

Richard Furman, M.D., shared insights into CLL treatments at a special session of the 2016 Annual ASH Meeting on Hematologic Malignancies. Read more

Rache Simmons, M.D., discusses a new non-surgical deep-freezing treatment for breast cancer. Read more

While chemotherapy kills the most common type of bladder cancer, urothelial cancer, it also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant, according to Bishoy Faltas and colleagues. Read more

David Rickman, Ph.D., and colleagues have identified a gene that appears to regulate the change from prostate adenocarcinoma to neuroendocrine prostate cancer. Read more

Jeffrey Greenfield, M.D., Ph.D., speaks out about the need for wider - and speedier - use of the FDA compassionate use exception. Read more

A new collaboration will be formed to help further data analysis for the Cancer Genome Atlas project, thanks to a $490,000 grant from the National Cancer Institute. Read more

A deep-freezing technique known as cryoablation is a viable alternative to traditional surgery in many early-stage breast cancers, according to Rache Simmons, M.D. Read more

The Weill Cornell Medicine Leukemia Program is part of collaborative research into myelodysplastic syndromes (MDS). Read more

Researchers from the lab of Olivier Elemento, Ph.D., have developed a promising new AI tool that better predicts which drug candidates are likely to be too toxic. Read more